FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013751858> ?p ?o ?g. }

• W2013751858 endingPage "487" @default.
• W2013751858 startingPage "481" @default.
• W2013751858 abstract "Background The need to recognize Alzheimer's disease (AD) as early as possible led us to evaluate the predictive value of amyloid β(1-42) (Aβ42), total tau (tau), and phosphorylated tau (ptau) in cerebrospinal fluid (CSF) for clinical progression in patients with subjective complaints. Methods We recruited nondemented patients with subjective complaints (i.e., criteria for mild cognitive impairment [MCI] not fulfilled) from our memory clinic. We assessed the predictive value of CSF Aβ42, tau, and ptau for clinical progression using Cox proportional hazards models adjusted for age, gender, and baseline findings on the Mini-Mental State Examination (MMSE). Clinical progression was defined as progression to MCI or AD. Results We included 127 patients with subjective complaints (age 60 ± 10 years, 61 [48%] females, MMSE 29 ± 1). At baseline, Aβ42 and tau were abnormal in 20 patients (both 16%), and ptau in 32 patients (25%). Thirteen patients (10%) progressed to MCI (n = 11) or AD (n = 2). Aβ42 was the strongest predictor of progression to MCI or AD with an adjusted hazard ratio (HR) of 16.0 (3.8–66.4). The adjusted HR associated with tau was 2.8 (0.9–9.2) and with ptau 2.6 (0.8–8.2). Combinations of biomarkers had a lower predictive value than Aβ42 alone. Conclusion Low Aβ42 was the strongest predictor of clinical progression in patients with subjective complaints. These results are in line with the hypothesis that the cascade of pathologic events starts with deposition of Aβ42, whereas neuronal degeneration and hyperphosphorylation of tau are more downstream events, closer to clinical manifestation of AD." @default.
• W2013751858 created "2016-06-24" @default.
• W2013751858 creator A5008906120 @default.
• W2013751858 creator A5014854647 @default.
• W2013751858 creator A5025870220 @default.
• W2013751858 creator A5038926287 @default.
• W2013751858 creator A5059183048 @default.
• W2013751858 creator A5062035305 @default.
• W2013751858 creator A5075394738 @default.
• W2013751858 date "2012-12-10" @default.
• W2013751858 modified "2023-10-17" @default.
• W2013751858 title "Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints" @default.
• W2013751858 cites W1515585636 @default.
• W2013751858 cites W1596429639 @default.
• W2013751858 cites W1973176942 @default.
• W2013751858 cites W1975103375 @default.
• W2013751858 cites W1985747467 @default.
• W2013751858 cites W1989796871 @default.
• W2013751858 cites W2012629748 @default.
• W2013751858 cites W2021195496 @default.
• W2013751858 cites W2027509450 @default.
• W2013751858 cites W2031489026 @default.
• W2013751858 cites W2032122310 @default.
• W2013751858 cites W2033572099 @default.
• W2013751858 cites W2035680108 @default.
• W2013751858 cites W2045311514 @default.
• W2013751858 cites W2051489981 @default.
• W2013751858 cites W2052132290 @default.
• W2013751858 cites W2052824383 @default.
• W2013751858 cites W2057771377 @default.
• W2013751858 cites W2060212076 @default.
• W2013751858 cites W2061699647 @default.
• W2013751858 cites W2065535274 @default.
• W2013751858 cites W2075275965 @default.
• W2013751858 cites W2075348467 @default.
• W2013751858 cites W2084972185 @default.
• W2013751858 cites W2108475007 @default.
• W2013751858 cites W2116551228 @default.
• W2013751858 cites W2129497119 @default.
• W2013751858 cites W2131830246 @default.
• W2013751858 cites W2132387058 @default.
• W2013751858 cites W2146788881 @default.
• W2013751858 cites W2156220037 @default.
• W2013751858 cites W2157110881 @default.
• W2013751858 cites W2158415185 @default.
• W2013751858 cites W2159122349 @default.
• W2013751858 cites W2166416515 @default.
• W2013751858 cites W2167834847 @default.
• W2013751858 cites W2167840686 @default.
• W2013751858 cites W2397310495 @default.
• W2013751858 cites W4322697611 @default.
• W2013751858 cites W9634772 @default.
• W2013751858 doi "https://doi.org/10.1016/j.jalz.2012.08.004" @default.
• W2013751858 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23232269" @default.
• W2013751858 hasPublicationYear "2012" @default.
• W2013751858 type Work @default.
• W2013751858 sameAs 2013751858 @default.
• W2013751858 citedByCount "166" @default.
• W2013751858 countsByYear W20137518582013 @default.
• W2013751858 countsByYear W20137518582014 @default.
• W2013751858 countsByYear W20137518582015 @default.
• W2013751858 countsByYear W20137518582016 @default.
• W2013751858 countsByYear W20137518582017 @default.
• W2013751858 countsByYear W20137518582018 @default.
• W2013751858 countsByYear W20137518582019 @default.
• W2013751858 countsByYear W20137518582020 @default.
• W2013751858 countsByYear W20137518582021 @default.
• W2013751858 countsByYear W20137518582022 @default.
• W2013751858 countsByYear W20137518582023 @default.
• W2013751858 crossrefType "journal-article" @default.
• W2013751858 hasAuthorship W2013751858A5008906120 @default.
• W2013751858 hasAuthorship W2013751858A5014854647 @default.
• W2013751858 hasAuthorship W2013751858A5025870220 @default.
• W2013751858 hasAuthorship W2013751858A5038926287 @default.
• W2013751858 hasAuthorship W2013751858A5059183048 @default.
• W2013751858 hasAuthorship W2013751858A5062035305 @default.
• W2013751858 hasAuthorship W2013751858A5075394738 @default.
• W2013751858 hasConcept C126322002 @default.
• W2013751858 hasConcept C143998085 @default.
• W2013751858 hasConcept C207103383 @default.
• W2013751858 hasConcept C2776656118 @default.
• W2013751858 hasConcept C2779134260 @default.
• W2013751858 hasConcept C2779651940 @default.
• W2013751858 hasConcept C2984915365 @default.
• W2013751858 hasConcept C3019719930 @default.
• W2013751858 hasConcept C44249647 @default.
• W2013751858 hasConcept C50382708 @default.
• W2013751858 hasConcept C71924100 @default.
• W2013751858 hasConceptScore W2013751858C126322002 @default.
• W2013751858 hasConceptScore W2013751858C143998085 @default.
• W2013751858 hasConceptScore W2013751858C207103383 @default.
• W2013751858 hasConceptScore W2013751858C2776656118 @default.
• W2013751858 hasConceptScore W2013751858C2779134260 @default.
• W2013751858 hasConceptScore W2013751858C2779651940 @default.
• W2013751858 hasConceptScore W2013751858C2984915365 @default.
• W2013751858 hasConceptScore W2013751858C3019719930 @default.
• W2013751858 hasConceptScore W2013751858C44249647 @default.
• W2013751858 hasConceptScore W2013751858C50382708 @default.

• next